Click to view your profile
Click to search for condition or expert
Click to open main menu
Non-Alcoholic Fatty Liver Disease Latest Advances
Find the Latest Research About Non-Alcoholic Fatty Liver Disease
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/06/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 507 publications
See more filters
Robotic versus laparoscopic major hepatectomy for hepatocellular carcinoma: short-term outcomes from a single institution.
Condition:
Hepatocellular Carcinoma (HCC)
Journal:
BMC surgery
Treatment Used:
Robotic vs. Laparoscopic Major Hepatectomy
Number of Patients:
131
Published:
December 17, 2022
VIEW PUBLICATION
Effects of Robuvit® on the progression of non-alcoholic fatty liver disease.
Condition:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Journal:
Minerva gastroenterology
Treatment Used:
Robuvit
Number of Patients:
34
Published:
December 12, 2022
VIEW PUBLICATION
Pharmacotherapeutic efficacy on noninvasive fibrosis progression in nonalcoholic fatty liver disease: a systematic review and network meta-analysis.
Condition:
Noninvasive Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
Journal:
European journal of gastroenterology & hepatology
Treatment Used:
Semaglutide, Obeticholic Acid, Firsocostat, Cilofexor, and Lubiprostone
Number of Patients:
6932
Published:
December 05, 2022
VIEW PUBLICATION
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy.
Condition:
Non-Alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM)
Journal:
Terapevticheskii arkhiv
Treatment Used:
Low-Calorie, Fat-Restricted, High-Fiber Diet and Urosodeoxycholic Acid
Published:
December 05, 2022
VIEW PUBLICATION
Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
Condition:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Journal:
Frontiers in endocrinology
Treatment Used:
Aerobic Exercise
Published:
November 21, 2022
VIEW PUBLICATION
Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Condition:
Metabolic-Associated Fatty Liver Disease (MAFLD)
Journal:
Frontiers in endocrinology
Treatment Used:
Probiotics
Number of Patients:
772
Published:
November 21, 2022
VIEW PUBLICATION
Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs.
Condition:
Nonalcoholic Steatohepatitis
Journal:
Medicine
Treatment Used:
Pioglitazone
Number of Patients:
1217
Published:
November 19, 2022
VIEW PUBLICATION
Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial.
Condition:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Journal:
Scientific reports
Treatment Used:
Helicobacter Pylori (H. pylori) Eradication
Number of Patients:
200
Published:
November 14, 2022
VIEW PUBLICATION
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Condition:
Hypertriglyceridemia
Journal:
The New England journal of medicine
Treatment Used:
Pemafibrate
Number of Patients:
10497
Published:
November 07, 2022
VIEW PUBLICATION
Modification of dietary patterns in patients with non-alcoholic steatohepatitis.
Condition:
Non-Alcoholic Steatohepatitis (NASH)
Journal:
Terapevticheskii arkhiv
Treatment Used:
Diet Modifications
Number of Patients:
0
Published:
October 26, 2022
VIEW PUBLICATION
Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH.
Condition:
Nonalcoholic Steatohepatitis (NASH)
Journal:
Hepatology communications
Treatment Used:
Rencofilstat (RCF)
Number of Patients:
49
Published:
October 22, 2022
VIEW PUBLICATION
Effects of time-restricted feeding (16/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: A randomized controlled trial.
Condition:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Journal:
Nutrition (Burbank, Los Angeles County, Calif.)
Treatment Used:
Time-Restricted Feeding (TRF) and Low-Sugar Diet
Number of Patients:
0
Published:
October 18, 2022
VIEW PUBLICATION
Showing 1-12 of 507
Next
Last Updated: 01/06/2023